✦ LIBER ✦

Stent selection in clinical practice: Have clinical trials provided the evidence we need?

✍ Scribed by Jeffrey J. Popma

Book ID: 117842560
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 64 KB
Volume: 142
Category: Article
ISSN: 1097-6744
DOI: 10.1067/mhj.2001.117322

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Selecting end points in clinical trials:

Selecting end points in clinical trials: What evidence do we really need to evaluate a new treatment?

✍ John Spertus 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 58 KB

119: Do imaging biomarkers provide the t

119: Do imaging biomarkers provide the tools we need in CHD risk assessment and clinical trials?

📂 Article 📅 2008 🏛 Elsevier 🌐 English ⚖ 78 KB

If we have bandwagons, magic bullets, an

If we have bandwagons, magic bullets, and theoretical constructs, why do we need randomized clinical trials in transfusion medicine and perioperative hemostasis?

✍ Jean-François Hardy; Philippe Van der Linden; Dean Fergusson 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 French ⚖ 148 KB

Clinical perspective: Have the results o

Clinical perspective: Have the results of recent clinical trials of lipid-lowering therapies influenced the way we should practice? A Latin American perspective of current issues in clinical lipidology

✍ Raul D. Santos; Alberto J. Lorenzatti; Carlos Fernandez Barros; Edgardo Escobar 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 319 KB

The Alberta Stroke Program Early CT Scor

The Alberta Stroke Program Early CT Score in clinical practice: what have we learned?

✍ V. Puetz; I. Dzialowski; M. D. Hill; A. M. Demchuk 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 556 KB

Cardiovascular Clinical Trials (Putting

Cardiovascular Clinical Trials (Putting the Evidence into Practice) || Randomized Controlled Trials in Cardiac Surgery: Is there any Alternative?

✍ Flather, Marcus D.; Bhatt, Deepak L.; Geisler, Tobias 📂 Article 📅 2012 🏛 Blackwell Publishing Ltd. 🌐 English ⚖ 178 KB

The pace of therapeutic advances in the treatment of cardiovascular diseases is rapid, and new clinically-relevant information appears with such frequency that it can be extremely challenging for clinicians to keep up. Still, knowledge and interpretation of major clinical trials is crucial for the